Robert Gerstl

Array ( [id] => 6548943 [patent_doc_number] => 20020137928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action' [patent_app_type] => new [patent_app_number] => 09/939829 [patent_app_country] => US [patent_app_date] => 2001-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13335 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137928.pdf [firstpage_image] =>[orig_patent_app_number] => 09939829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202894 [patent_doc_number] => 06720342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-13 [patent_title] => 'Heterocyclic compounds and their preparation and use' [patent_app_type] => B2 [patent_app_number] => 09/940963 [patent_app_country] => US [patent_app_date] => 2001-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8531 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720342.pdf [firstpage_image] =>[orig_patent_app_number] => 09940963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1256802 [patent_doc_number] => 06667412 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-23 [patent_title] => 'Nitrile compound' [patent_app_type] => B1 [patent_app_number] => 09/914349 [patent_app_country] => US [patent_app_date] => 2001-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5636 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667412.pdf [firstpage_image] =>[orig_patent_app_number] => 09914349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1397305 [patent_doc_number] => 06541493 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Crystals of 5-6-(2-fluorobenzyl)oxy-2-naphthylmethyl-2,4-thiazolidinedione' [patent_app_type] => B1 [patent_app_number] => 09/856295 [patent_app_country] => US [patent_app_date] => 2001-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5151 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541493.pdf [firstpage_image] =>[orig_patent_app_number] => 09856295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241365 [patent_doc_number] => 06683188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Cyanine dye' [patent_app_type] => B1 [patent_app_number] => 09/913730 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8372 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683188.pdf [firstpage_image] =>[orig_patent_app_number] => 09913730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636408 [patent_doc_number] => 06380251 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents' [patent_app_type] => B1 [patent_app_number] => 09/903971 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5255 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380251.pdf [firstpage_image] =>[orig_patent_app_number] => 09903971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521354 [patent_doc_number] => 06414022 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-07-02 [patent_title] => 'Cyclopentane(ENE)heptenoic or heptenoic acids and derivatives thereof useful as therapeutic agents' [patent_app_type] => B2 [patent_app_number] => 09/919318 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8685 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414022.pdf [firstpage_image] =>[orig_patent_app_number] => 09919318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1587261 [patent_doc_number] => 06359181 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents' [patent_app_type] => B1 [patent_app_number] => 09/915908 [patent_app_country] => US [patent_app_date] => 2001-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 11853 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359181.pdf [firstpage_image] =>[orig_patent_app_number] => 09915908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5952264 [patent_doc_number] => 20020007060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => 'Reverse hydroxamate inhibitors of matrix metalloproteinases' [patent_app_type] => new [patent_app_number] => 09/905242 [patent_app_country] => US [patent_app_date] => 2001-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60909 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20020007060.pdf [firstpage_image] =>[orig_patent_app_number] => 09905242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640153 [patent_doc_number] => 06395762 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists' [patent_app_type] => B1 [patent_app_number] => 09/904155 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23826 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395762.pdf [firstpage_image] =>[orig_patent_app_number] => 09904155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467382 [patent_doc_number] => 06458817 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists' [patent_app_type] => B1 [patent_app_number] => 09/903802 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11768 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 360 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458817.pdf [firstpage_image] =>[orig_patent_app_number] => 09903802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575183 [patent_doc_number] => 06469004 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Benzoheterocycles and their uses as MEK inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/889059 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16471 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1065 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469004.pdf [firstpage_image] =>[orig_patent_app_number] => 09889059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064423 [patent_doc_number] => 20020032338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Hydrolytic kinetic resolution of cyclic substrates' [patent_app_type] => new [patent_app_number] => 09/899516 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 32452 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032338.pdf [firstpage_image] =>[orig_patent_app_number] => 09899516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454166 [patent_doc_number] => 06462077 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Thromboxane ligands without blood clotting side effects' [patent_app_type] => B1 [patent_app_number] => 09/899713 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9393 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462077.pdf [firstpage_image] =>[orig_patent_app_number] => 09899713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440451 [patent_doc_number] => 20020128315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Leukotriene B4 antagonist compounds and method for treatment' [patent_app_type] => new [patent_app_number] => 09/897451 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15424 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128315.pdf [firstpage_image] =>[orig_patent_app_number] => 09897451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1319710 [patent_doc_number] => 06605629 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-12 [patent_title] => 'Neurotrophin production secretion promoting agent' [patent_app_type] => B1 [patent_app_number] => 09/868304 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 36220 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605629.pdf [firstpage_image] =>[orig_patent_app_number] => 09868304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1349797 [patent_doc_number] => 06583289 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Curative for anaerobic adhesive compositions' [patent_app_type] => B1 [patent_app_number] => 09/868626 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2941 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/583/06583289.pdf [firstpage_image] =>[orig_patent_app_number] => 09868626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291887 [patent_doc_number] => 20020055528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same' [patent_app_type] => new [patent_app_number] => 09/887922 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18821 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055528.pdf [firstpage_image] =>[orig_patent_app_number] => 09887922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575911 [patent_doc_number] => 06469207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-10-22 [patent_title] => 'Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors' [patent_app_type] => B2 [patent_app_number] => 09/884462 [patent_app_country] => US [patent_app_date] => 2001-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13851 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 332 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469207.pdf [firstpage_image] =>[orig_patent_app_number] => 09884462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6716505 [patent_doc_number] => 20030027853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => ' 3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure' [patent_app_type] => new [patent_app_number] => 09/882720 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4080 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027853.pdf [firstpage_image] =>[orig_patent_app_number] => 09882720 [rel_patent_id] =>[rel_patent_doc_number] =>)